Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2022 07:10 ET | Source: Pacific Biosciences of California, Inc.

PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology

MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration with Genomics...
January 11, 2022 07:05 ET | Source: Pacific Biosciences of California, Inc.

PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis

MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced a research collaboration with...
January 11, 2022 07:00 ET | Source: Pacific Biosciences of California, Inc.

PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations

MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue...
January 07, 2022 09:00 ET | Source: Pacific Biosciences of California, Inc.

Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe

MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical...
January 06, 2022 09:00 ET | Source: Pacific Biosciences of California, Inc.; Azenta Life Sciences

Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems

MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The...
January 05, 2022 09:00 ET | Source: Pacific Biosciences of California, Inc.

PacBio and Care4Rare Consortium Collaborate on Rare Disease Research Study

MENLO PARK, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- PacBio, a leading provider of high-quality, long-read sequencing platforms, and the Care4Rare Canada Consortium (Care4Rare) announce today they...
January 04, 2022 16:05 ET | Source: Pacific Biosciences of California, Inc.

PacBio to Present at Upcoming Investor Conference

MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking virtually at the following investor conference: 40th Annual J.P. Morgan Healthcare...
December 28, 2021 09:00 ET | Source: Pacific Biosciences of California, Inc.

PacBio’s New HiFiViral Surveillance Kit Performance is Not Impacted by Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes for All Circulating Variants

MENLO PARK, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate, long-read sequencing technology, today announced that its new...
December 07, 2021 09:00 ET | Source: Pacific Biosciences of California, Inc.

PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases

MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and the UCLA Institute for Precision Health and...
December 03, 2021 17:00 ET | Source: Pacific Biosciences of California, Inc.

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...